As previously reported, OKIE was the catalyst for the formation of an exciting, cutting edge medical company: Nanomed Targeting Systems, Inc. At the 2007 biomedical conference sponsored by OKIE and the Oklahoma Department of Commerce, Israeli businessman Alex Harel met Dr. Ken Dormer, an OU professor, medical researcher and a leading authority in nanoparticle medicine.

That meeting led to the development of a technology for treating atrial
fibrillation using powerful magnets to direct drug-encased magnetic
nanoparticles into optimal position for effectiveness of the drugs. This
system promises to be less invasive, less costly and possibly more effective than surgery.

Nanomed has completed
testing its first prototype, in vitro (laboratory) and in vivo (animal) research. Currently in the pre-clinical phase, they are preparing for human trials and the FDA approval process.

Two dinner meetings are scheduled to present their story to the medical community and interested investors: Tuesday, September 20 at the Jewish Federation of Tulsa and Thursday, September 22 at the Jewish Federation of Greater Oklahoma City.

For more information visit www.nanomed-systems.com or
you can contact them directly:

NanoMed Targeting Systems Inc.
2500 S. Broadway Ave., Suite 130
Edmond, OK 73013

Tel. (405) 806-0646
Cell (646) 641-4747
Fax (206) 339-4909
E-mail: alex@nanomed-systems.com